NCT05533892 Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC Status RECRUITING Phase PHASE1
NCT05528952 Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT05520788 Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing Status RECRUITING Phase N/A
NCT05516628 Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT05502458 Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor Status COMPLETED Phase PHASE2
NCT05497531 Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers Status RECRUITING Phase NA
NCT05497453 A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene Status TERMINATED Phase PHASE1/PHASE2
NCT05493332 HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC Status UNKNOWN Phase PHASE2
NCT05491889 Outcome of Hepatocellular Carcinoma Patients With Portal Vein Thrombosis After Trans-Arterial Chemo Embolization Status UNKNOWN Phase N/A
NCT05490147 Effect of Low Tidal Ventilation on Intraoperative Bleeding in Laparoscopic Major Hepatectomy Status UNKNOWN Phase NA
NCT05489289 A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection Status RECRUITING Phase PHASE3
NCT05488587 Serum Levels of Some Trace Elements in Hepatocellular Carcinoma Patients Status UNKNOWN Phase N/A
NCT05484908 Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC Status RECRUITING Phase NA
NCT05476432 HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study Status RECRUITING Phase PHASE3
NCT05475613 Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation Status RECRUITING Phase PHASE2